Xenetic Biosciences, Inc. (XBIO)
Xenetic Biosciences, Inc. (XBIO) is a biotechnology company focused on developing innovative biologic and immuno-oncology therapies. The company's portfolio includes proprietary platforms for novel cancer treatments, aiming to harness the immune system to fight cancer and other diseases. Xenetic collaborates with partners to advance its pipeline, emphasizing scalable biologic manufacturing and translational research.
Company News
Xenetic Biosciences (XBIO) delivered earnings and revenue surprises of 1.27% and 21.39%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
HC Wainwright has downgraded Xenetic Biosciences Inc (NASDAQ: XBIO) from Buy to Neutral, citing pending clinical path visibility. In the Q1 earnings release, the company announced continued progress with the DNase-based oncology program toward Phase 1 study for pancreatic carcinoma and other locally advanced or metastatic solid tumors. Xeneti...
Penny stocks to buy according to analysts with price targets up to 300% right now. The post 5 Penny Stocks Analysts Say To Buy With Targets Up To 300% appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.